Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 15, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, September 14, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Derik De Bruin Downgraded (TXG) to Hold and Held Target at $180 on, Sep 14th, 2021
Derik De Bruin of B of A Securities, Downgraded "10x Genomics, Inc." (TXG) to Hold and Held Target at $180 on, Sep 14th, 2021.
Derik has made no other calls on TXG in the last 4 months.
There is 1 other peer that has a rating on TXG. Out of the 1 peers that are also analyzing TXG, 0 agree with Derik's Rating of Hold.
This is the rating of the analyst that currently disagrees with Derik
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $220 on, Thursday, August 5th, 2021
